Nov 15 (Reuters) - THERACLION SA ALTHER.PA :
* CO AND LEAD INVESTIGATOR PRESENT PRELIMINARY RESULTS OF
ECHOTHERAPY IN THE TREATMENT OF VARICOSE VEINS
* NO SIGNIFICANT SIDE EFFECTS WERE REPORTED DURING
TREATMENT AND
FOLLOW-UP PERIOD
* TRIAL ON THERACLION'S ECHOTHERAPY WILL ENROLL 35 PATIENTS
AND
WILL BE FOLLOWED-UP FOR 3 MTHS AFTER PROCEDURE
* FOR ALL PATIENTS TREATED IN STUDY, PROCEDURE WAS
FEASIBLE
* NO PROCEDURES WERE INTERRUPTED OR CANCELLED DUE TO
TECHNICAL OR
MEDICAL REASONS RELATED TO TREATMENT
Source text : http://bit.ly/2huGRoW
Further company coverage: ALTHER.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))